Novartis Venture Fund — 2023 Investments
1 investments dated 2023 · listed companies and verified rows first · show all
Tagworks Pharmaceuticalstagworkspharma.comin𝕏Jun 2023
Tagworks Pharmaceuticals develops cancer therapies using its Click-to-Release platform, a chemical reaction that activates antibody-drug conjugates (ADCs), masked immunomodulators, and other prodrugs on-target while deactivating radioimmunotherapies off-target.
BiotechHealthtechMedical DevicesNijmegen, NL
Co-investorsBifLightstone VenturesNew Enterprise Associates (NEA)Ysios CapitalGilde HealthcareOost NL
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.